Cortexyme Announces Leadership Appointments to Support Advancement of Atuzaginstat and Pipeline Expansion
Press release content from Business Wire. The AP news staff was not involved in its creation. Cortexyme Announces Leadership Appointments to Support Advancement of Atuzaginstat and Pipeline Expansion February 10, 2021 GMT SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Feb 10, 2021-- Cortexyme, Inc. (Nasdaq: CRTX), a company advancing a pivotal trial in Alzheimer’s disease on schedule to be announced in Q4 2021 and a pipeline of therapeutics for degenerative diseases, today announced a series of leadership appointments to support the continued advancement and commercial planning of atuzaginst...